-

Lost Money in The Beauty Health Company? Gibbs Law Group Investigates Potential Securities Law Violations

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Law Group announces that a class action lawsuit has been filed against The Beauty Health Company (NASDAQ: SKIN). Shares of The Beauty Health Company plummeted 64% on Tuesday, November 14, 2023, after releasing 2023 Q3 results indicating it was lowering its 2023 net sales guidance due to lower-than-expected revenue, suspending its long-term 2025 financial outlook, and lowering other key metrics. The Company also announced the departure of its president and CEO, effective November 19, 2023. Gibbs Law Group encourages SKIN investors to contact us to discuss their legal rights and options.

If you are a SKIN shareholder who suffered losses, click here or call (888) 410-2925.

On Monday, November 13, 2023, The Beauty Health Company published its 2023 Q3 financial results, stating that “the quarter was overshadowed by lower-than-expected U.S. revenue and $63.1 million in restructuring charges related to device upgrades of early generation Syndeo devices.” As a result, the company has suspended its long-term 2025 financial outlook, is revising its 2023 fiscal year net sales guidance to a range of $385-$400 million and is adjusting its EBITDA margin guidance to a range of 5%-6%. Following the weak earnings results, the company announced that its president and CEO, Andrew Stanleick, is stepping down, effective November 19, 2023.

Following this news, The Beauty Health Company stock plummeted by 64% on Tuesday, November 14, 2023, causing significant harm to investors.

What Should SKIN Investors Do?

If you invested in The Beauty Health Company, visit our website, or contact our securities team directly at (888) 410-2925 to discuss how you may be able to recover your losses. Our investigation concerns whether The Beauty Health Company has violated federal securities laws by providing false or misleading statements to investors.

About Gibbs Law Group

Gibbs Law Group represents investors throughout the country in securities litigation to correct abusive corporate governance practices, breaches of fiduciary duty, and proxy violations. The firm has recovered over a billion dollars for its clients against some of the world’s largest corporations, and our attorneys have received numerous honors for their work, including “Best Lawyers in America,” “Top Plaintiff Lawyers in California,” “California Lawyer Attorney of the Year,” “Class Action Practice Group of the Year,” “Consumer Protection MVP,” and “Top Women Lawyers in California.”

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

EILEEN EPSTEIN
PHONE: 510.350.9728
EMAIL: EJE@CLASSLAWGROUP.COM

Gibbs Law Group

NASDAQ:SKIN

Release Versions
$Cashtags
Hashtags

Contacts

EILEEN EPSTEIN
PHONE: 510.350.9728
EMAIL: EJE@CLASSLAWGROUP.COM

More News From Gibbs Law Group

Class Action Lawsuit Filed Against Richtech Robotics; Investors Urged to Contact Award-Winning Firm, Gibbs Mura

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura announces a class action lawsuit has been filed on behalf of Richtech Robotics Inc. (RR) investors....

Richtech Robotics Inc. Under Investigation After 20% Stock Drop

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Richtech Robotics Inc. (“Richtech Robotics”) fell over 20% in intraday trading on January 29, 2026, after Hunterbrook Media published a report accusing the company of misrepresenting its “collaboration” with Microsoft and missing its 10-K extended filing deadline. Gibbs Mura is investigating a potential Richtech Robotics Inc. (NASDAQ: RR) Securities Class Action Lawsuit concerning whether Richtech Robotics has violated federal securities laws by provi...

Kaiser Agrees To Historic $556 Million To Settle Whistleblower Lawsuit Over Alleged Medicare Fraud

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura is pleased to announce that Kaiser Permanente has agreed to pay $556 million to resolve allegations of Medicare Advantage risk-adjustment fraud. This is believed to be the largest Medicare Part C qui tam settlement ever reached, and is one of the largest whistleblower settlements brought under the False Claims Act settlements in recent years. Our firm’s client, Ronda Osinek was the first whistleblower to file a complaint against Kaiser in the long-ru...
Back to Newsroom